Your browser is no longer supported. Please, upgrade your browser.
Settings
SPPI Spectrum Pharmaceuticals, Inc. daily Stock Chart
SPPI [NASD]
Spectrum Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.53 Insider Own3.50% Shs Outstand68.90M Perf Week-1.82%
Market Cap445.78M Forward P/E- EPS next Y-0.97 Insider Trans0.00% Shs Float61.17M Perf Month-4.99%
Income-34.50M PEG- EPS next Q-0.29 Inst Own70.20% Short Float14.21% Perf Quarter-15.42%
Sales167.80M P/S2.66 EPS this Y-10.80% Inst Trans1.52% Short Ratio10.92 Perf Half Y26.12%
Book/sh3.17 P/B2.04 EPS next Y7.60% ROA-8.00% Target Price9.33 Perf Year-5.55%
Cash/sh1.92 P/C3.36 EPS next 5Y- ROE-15.90% 52W Range4.14 - 7.74 Perf YTD7.30%
Dividend- P/FCF94.85 EPS past 5Y3.80% ROI-13.20% 52W High-16.02% Beta1.50
Dividend %- Quick Ratio2.80 Sales past 5Y17.00% Gross Margin83.60% 52W Low57.00% ATR0.16
Employees212 Current Ratio2.90 Sales Q/Q13.70% Oper. Margin-15.10% RSI (14)40.41 Volatility3.06% 2.42%
OptionableYes Debt/Eq0.48 EPS Q/Q63.90% Profit Margin-20.60% Rel Volume0.37 Prev Close6.47
ShortableYes LT Debt/Eq0.48 EarningsAug 04 AMC Payout- Avg Volume796.38K Price6.50
Recom2.00 SMA20-1.43% SMA50-5.78% SMA2007.61% Volume268,441 Change0.46%
Nov-05-15Reiterated RBC Capital Mkts Outperform $13 → $12
Aug-07-15Reiterated RBC Capital Mkts Outperform $12 → $13
Apr-02-15Initiated FBR Capital Outperform $9
Feb-23-15Downgrade ROTH Capital Buy → Neutral $15 → $7
Jul-15-14Upgrade R. F. Lafferty Sell → Neutral $7.50
Oct-07-13Initiated HC Wainwright Buy $15
May-29-13Initiated Burrill Institutional Research Mkt Outperform $12
Mar-13-13Reiterated RBC Capital Mkts Outperform $19 → $16
Mar-13-13Downgrade WallachBeth Buy → Sell $20 → $5.50
May-02-11Reiterated MLV Capital Buy $12.50 → $20.50
Mar-25-11Initiated RBC Capital Mkts Outperform $12
Dec-07-10Reiterated Morgan Joseph Buy $8 → $10
Jan-12-10Upgrade Morgan Joseph Hold → Buy $8
Oct-14-09Reiterated Rodman & Renshaw Mkt Outperform $10 → $8
Sep-08-09Downgrade Morgan Joseph Buy → Hold
Sep-09-08Initiated Morgan Joseph Buy $5
Apr-23-08Downgrade Oppenheimer Outperform → Perform
Mar-18-08Downgrade Brean Murray Buy → Hold
Nov-01-07Reiterated Friedman Billings Mkt Perform $5.50 → $4
Oct-31-07Reiterated Rodman & Renshaw Mkt Outperform $8 → $6
Jul-20-16 12:53PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : July 20, 2016
Jul-13-16 07:00AM  Spectrum Pharmaceuticals Settles FOLOTYN® (pralatrexate injection) ANDA Patent Litigation Business Wire
06:29AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Jul-06-16 02:41PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : July 6, 2016
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Cantor Fitzgeralds 2nd Annual Healthcare Conference on July 13th Business Wire
Jul-01-16 05:15PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-28-16 03:52PM  Forget Valeant, Invest in These Attractive Drug Stocks Instead
Jun-21-16 01:14PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : June 21, 2016
Jun-09-16 06:02AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Jun-01-16 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2016 Healthcare Conference on June 8th Business Wire
May-31-16 07:02AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events
May-25-16 07:06AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events
May-18-16 10:53PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : May 19, 2016
May-17-16 04:10PM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q1, 2016 By the Numbers
May-13-16 01:04PM  SPECTRUM PHARMACEUTICALS INC Financials
May-11-16 03:03PM  Is Spectrum Pharmaceuticals Still a Buy After Surging Higher in April? at Motley Fool
May-06-16 05:39PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report +11.72%
01:27PM  Edited Transcript of SPPI earnings conference call or presentation 5-May-16 8:30pm GMT
07:00AM  Spectrum Pharmaceuticals Highlights an Oral Presentation on Apaziquone at the 2016 Annual Meeting of the American Urological Association Education and Research Inc. (AUA) in San Diego, California, May 6-10, 2016 Business Wire
May-05-16 04:25PM  Spectrum Pharma reports 1Q loss -8.05%
04:05PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:00PM  Spectrum Pharmaceuticals Reports First Quarter 2016 Financial Results and Pipeline Update Business Wire
07:07AM  Q1 2016 Spectrum Pharmaceuticals Inc Earnings Release - After Market Close CCBN
May-03-16 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2016 Healthcare Conference on May 10th Business Wire
Apr-28-16 07:00AM  Spectrum Pharmaceuticals Announces First Quarter 2016 Financial Results Teleconference and Webcast Business Wire
Apr-20-16 01:31AM  [$$] Companies Wind Up in the Penalty Box on Executive Pay at The Wall Street Journal
Apr-19-16 07:24PM  [$$] Companies Wind Up in the 'Penalty Box' on Executive Pay at The Wall Street Journal
Apr-07-16 12:57PM  Four Biotech Stocks To Consider As The Sector Breaks Out Accesswire
10:06AM  Existing Chemotherapy Drugs for Lymphoma
09:30AM  Six Technologies That Will Change Healthcare Accesswire
Mar-28-16 09:39AM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : March 28, 2016
Mar-24-16 04:56PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
Mar-15-16 07:00AM  FDA Grants Spectrum Pharmaceuticals Approval of EVOMELA (melphalan) for Injection Business Wire
Mar-14-16 05:27PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
04:07PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : March 14, 2016
12:39PM  XLV Rose Last Week, but Did It Reach Its 100-Day Moving Average?
12:29PM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q4, 2015 By the Numbers
Mar-11-16 07:12AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events +5.85%
Mar-10-16 11:08AM  Spectrum (SPPI) Incurs Narrower-than-Expected Loss in Q4 +9.18%
Mar-09-16 10:59PM  Edited Transcript of SPPI earnings conference call or presentation 9-Mar-16 9:30pm GMT
04:13PM  Spectrum Pharma reports 4Q loss
04:09PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:00PM  Spectrum Pharmaceuticals Reports Fourth Quarter 2015 and Full Year 2015 Financial Results and Pipeline Update Business Wire
07:07AM  Q4 2015 Spectrum Pharmaceuticals Inc Earnings Release - After Market Close
Mar-08-16 02:18PM  Spectrum Pharmaceuticals, Inc. Value Analysis (NASDAQ:SPPI) : March 8, 2016 -5.41%
Mar-07-16 08:21AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SPPI-US : March 7, 2016 +6.14%
07:00AM  Spectrum Pharmaceuticals Initiates Phase 2 Breast Cancer Trial for Poziotinib, a Novel Pan-HER Inhibitor Business Wire
Mar-02-16 07:00AM  Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2015 Financial Results Teleconference and Webcast Business Wire +7.74%
Feb-22-16 08:00AM  Biotechnology Stocks under Review -- Alnylam Pharma, Puma Biotechnology, Regeneron Pharma, and Spectrum Pharma Accesswire
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at 2016 RBC Capital Markets' Global Healthcare Conference on February 24 Business Wire
Feb-19-16 09:00AM  Labaton Sucharow LLP Announces Summary Notice Of Pendency Of Class Action, Proposed Settlement, And Motion For Attorneys' Fees And Expenses In In Re: Spectrum Pharmaceuticals, Inc., Securities Litigation PR Newswire +5.17%
07:00AM  Spectrum Pharmaceuticals Announces FDAs Acceptance of NDA Filing for EOquin® (apaziquone for intravesical instillation) Business Wire
Feb-01-16 07:21PM  Spectrum (SPPI) Initiates Phase III Study on SPI-2012
Jan-29-16 07:19AM  Spectrum Pharmaceuticals Begins Enrolling Patients in Registrational Trial of SPI-2012, a Novel, Long Acting G-CSF in Patients with Breast Cancer at noodls
07:00AM  Spectrum Pharmaceuticals Begins Enrolling Patients in Registrational Trial of SPI-2012, a Novel, Long Acting G-CSF in Patients with Breast Cancer Business Wire
Jan-12-16 08:00AM  Biotechnology Stocks Technical Data -- Regulus Therapeutics, Progenics Pharma, Spectrum Pharma, and Sorrento Therapeutics Accesswire
Jan-11-16 07:03AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:00AM  Spectrum Pharmaceuticals Signs a Strategic Partnership With Servier Canada Business Wire
Jan-07-16 08:18AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : January 7, 2016 -5.07%
Jan-05-16 06:07AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
Dec-29-15 08:00AM  Healthcare Sector Equities Under the Scanner -- Xenoport, Tetraphase Pharma, uniQure, and Spectrum Pharma Accesswire
Dec-22-15 09:48AM  Spectrum Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers
Dec-18-15 06:12PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of January 4, 2016 - SPPI Accesswire
08:00AM  Pre-market Equity Watch on Biotechnology -- Agenus, Arrowhead Research, Spectrum Pharma, and Infinity Pharma Accesswire
Dec-16-15 10:41AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events +8.53%
07:00AM  Spectrum Pharmaceuticals Announces Agreement with FDA on the Special Protocol Assessment (SPA) for the Registrational Trial of SPI-2012, a Novel, Long Acting G-CSF in Patients with Breast Cancer Business Wire
Dec-15-15 03:22PM  TheGrantLawFirm, PLLC Withdraws Action on Behalf of Spectrum Pharmaceuticals, Inc. Purchasers Business Wire
11:01AM  INVESTOR ALERT: The Law Offices of Vincent Wong Remind Investors of Class Action Involving Spectrum Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of January 4, 2016 - SPPI GlobeNewswire
Dec-10-15 08:30AM  Marqibo® Made Available to Acute Lymphoblastic Leukemia Patients Through Global myTomorrows Platform PR Newswire
Dec-09-15 07:40PM  INVESTOR NOTICE: Lundin Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. and Urges Investors to Contact the Firm Business Wire
03:23PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Spectrum Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of January 4, 2016 - SPPI PR Newswire
02:16PM  Spectrum Pharmaceuticals, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors Business Wire
Dec-08-15 07:00AM  Spectrum Pharmaceuticals Highlights Four Abstracts on SPI-2012 and Poziotinib at the San Antonio Breast Cancer Symposium (SABCS) Business Wire
Dec-07-15 02:10PM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Dec-06-15 12:00PM  Spectrum Pharmaceuticals and Onxeo Announce Complete Response in 67% of Patients with Peripheral T-Cell Lymphoma in Combination of Belinostat (Beleodaq®) and Standard CHOP Business Wire
Dec-04-15 07:00AM  Spectrum Pharmaceuticals Highlights 18 Abstracts at the 57th Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida, December 5-8, 2015 Business Wire
Dec-03-15 06:24PM  Investor Alert: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 From Investment in Spectrum Pharmaceuticals, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit SPPI GlobeNewswire
03:39PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Spectrum Pharmaceuticals, Inc. and Urges Investors to Contact the Firm Business Wire
Dec-01-15 12:02PM  Spectrum Pharmaceuticals, Inc. Value Analysis (NASDAQ:SPPI) : December 1, 2015
09:15AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : December 1, 2015
Nov-30-15 03:59PM  INVESTOR ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Spectrum Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of January 4, 2016 - SPPI GlobeNewswire
Nov-29-15 08:59AM  Here is What Hedge Funds Think About Natural Health Trends Corp. (NHTC) at Insider Monkey
Nov-25-15 09:25AM  Market Data on Movers and Shakers - Research on TRAVELCENTERS OF AMERICA, Spectrum Pharmaceuticals, Ardelyx and Sportsmans Warehouse Holdings Accesswire
09:05AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events
Nov-22-15 05:05PM  Is Spectrum Pharmaceuticals, Inc. (SPPI) A Good Stock To Buy? at Insider Monkey
Nov-20-15 07:00AM  Spectrum Pharmaceuticals Submits Phase 2 Breast Cancer Protocol to FDA as Part of an Investigational New Drug (IND) Application for Poziotinib Business Wire
Nov-19-15 05:18PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Spectrum Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of January 4, 2016 SPPI GlobeNewswire
04:30PM  Spectrum (SPPI) Up on Selling Zevalin Rights to Mundipharma
09:20AM  Direction of Market Influences - Research on DHI Group, Trevena, Spectrum Pharmaceuticals and Douglas Dynamics Accesswire
Nov-18-15 06:07AM  SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
03:00AM  Spectrum Pharmaceuticals Divests Rights to ZEVALIN® (ibritumomab tiuxetan) in Japan and Select Other Ex-US Countries to Mundipharma Business Wire
Nov-17-15 12:11PM  TheGrantLawFirm, PLLC Files Class Action on Behalf of Spectrum Pharmaceuticals, Inc. Securities Purchasers Business Wire
Nov-12-15 10:25PM  DEADLINE ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Spectrum Pharmaceuticals, Inc. and Advises Shareholders to Contact the Firm Business Wire
06:17PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Spectrum Pharmaceuticals, Inc. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit Business Wire
06:00PM  Spectrum Phamaceuticals Shareholder Alert: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. has Been Commenced in the United States District Court for the District of Nev Marketwired
03:35PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of January 4, 2016 -- SPPI Marketwired
Nov-10-15 06:56PM  Lifshitz & Miller Law Firm Announces Investigation of Applied DNA Sciences Inc., Barrett Business Services Inc., First Niagara Financial Group, Fidelity & Guaranty Life, SORL Auto Parts, Inc., Spectrum Pharmaceuticals, and 6D Global Technol PR Newswire
10:32AM  Ligand (LGND) Beats on Q3 Earnings, Lowers 2015 Outlook
Nov-09-15 08:10AM  Scanning Stocks from Diverse Sectors - Research on Martha Stewart Living Omnimedia, Ocean Rig UDW, Avid Technology and Spectrum Pharmaceuticals Accesswire
Nov-06-15 11:24PM  Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Spectrum Pharmaceuticals, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit SPPI GlobeNewswire
Spectrum Pharmaceuticals, Inc., a biotechnology company, develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer, rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor to treat patients with relapsed or refractory PTCL; ZEVALIN injection for patients with follicular non-Hodgkin's lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation of the anticancer drug vincristine for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for patients with relapsed or refractory PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It is also developing POZIOTINIB for treating breast, gastric, colorectal, and lung cancers; EOQUIN for non-muscle invasive bladder cancer; and SPI-2012 for chemotherapy-induced neutropenia in patients with breast cancer. The company sells its drugs through a direct sales force in the United States; and through distributors in Europe. It has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG, Sloan-Kettering Institute, and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan, Inc.; collaboration agreement with Nippon Kayaku Co., Ltd.; licensing and collaboration agreement with TopoTarget A/S; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHROTRIYA RAJESH C MDChairman & CEODec 22Option Exercise4.23129,248546,719101,426Dec 23 04:03 PM
Krassner Stuart MitchellDirectorDec 01Option Exercise4.2615,00063,90052,988Dec 02 04:48 PM